Antiobesity Activity of Zingiber officinale

Sagar B. Patil; Snehal D. Kothavale.

doi:10.52711/0975-4385.2022.00044

Research Journal of Pharmacognosy and Phytochemistry

ISSN

0975-4385 (Online)
0975-2331 (Print)

Submit Article

Antiobesity Activity of Zingiber officinale

Author(s): Sagar B. Patil, Snehal D. Kothavale.

Email(s): snehalkothavale28@gmail.com

DOI: 10.52711/0975-4385.2022.00044

Address: Sagar B. Patil, Snehal D. Kothavale.
Rajarambapu College of Pharmacy, Kasegoan 415404.
*Corresponding Author

Published In: Volume - 14, Issue - 4, Year - 2022

View HTML

View PDF

ABSTRACT:
Obesity is a metabolic disorder that is linked to a wide spectrum of chronic diseases, increasing comorbidity and mortality significantly. The rhizome of Zingiber officinale Roscoe (Zingiberaceae) is widely used in Indian traditional medicine to cure a variety of ailments. The current study looked at the antiviral, radioprotective, anti-inflammatory, anticancer, and antioxidant properties of Z officinale, with an emphasis on Ayurvedic prescriptions. Metabolic syndromes (MetSs), which include diabetes, dyslipidemia, and cardiovascular disease, have emerged as a prevalent health concern in both industrialised and developing nations in recent years.

Keywords:

Cite this article:
Sagar B. Patil, Snehal D. Kothavale. Antiobesity Activity of Zingiber officinale. Research Journal of Pharmacognosy and Phytochemistry. 2022; 14(4):252-6. doi: 10.52711/0975-4385.2022.00044

Cite(Electronic):
Sagar B. Patil, Snehal D. Kothavale. Antiobesity Activity of Zingiber officinale. Research Journal of Pharmacognosy and Phytochemistry. 2022; 14(4):252-6. doi: 10.52711/0975-4385.2022.00044 Available on: https://rjpponline.org/AbstractView.aspx?PID=2022-14-4-5

REFERENCES:
1.   file:///C:/Users/Admin/Downloads/foods-08-00185.pdf
2.   file:///C:/Users/Admin/Downloads/Antiobesity_activity_of_Zingiber_officinale.pdf
3.   Langner E, Greifenberg S and Gruenwald J. Ginger: history and use. Advance Thera. 1998; 15;25-44.
4.   file:///C:/Users/Admin/Downloads/WakchaureGanguly2018NewChapter_LeninMediaPvt.Ltd.Delhi.pdf.
5.   Trease GE, Evans WC. Pharmacognosy, 12th ed. London, Baillieere Tindal. 1983
6.   Harborne JB. Phytochemical methods: a guide to modern techniques of plant analysis, IIIrd edn. Academic Press, London. 1998; pp. 193-204
7.   file:///C:/Users/Admin/DownloadsAntiobesity_activity_of_Zingiber_officinale.pdffile:///C:/Users/Admin/Downloads/foods-08-00185.pdf
8.   Wang CC, Chen LG, Lee LT and Yang LL. Effects of 6-gingerol, an antioxidant from ginger, on inducing apoptosis in human leukemic HL-60 cells. In Vivo. 2003; 17(6):641-645.
9.   Fuhrman B, Rosenblat M, Hayek T, Coleman R and Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic,apolipoprotein E-deficient mice. J Nutr. 2000; 130(5):1124-1131.
10.   Ma J, Jin X, Yang L and Liu ZL. Diarylheptanoids from the rhizomes of Zingiber officinale. Phytochemistry. 2004;65(8):1137-1143.
11.   Aggarwal BB and Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. BiochemPharmacol. 5-14-2006;71(10):1397-1421.
12.   Shukla, Y and Singh M. Cancer preventive properties of ginger: a brief review. Food ChemToxicol. 2007;45(5):683-690.
13.   Desai HG, Kalro RH and Choksi AP. Effect of ginger & garlic on DNA content of gastric aspirate. Indian J Med Res. 1990;92:139-141.
14.   Verma SK, Singh J, Khamesra R and Bordia A. Effect of ginger on platelet aggregation in man. Indian J Med Res. 1993;98:240-242
15.   Bhattarai S, Tran VH and Duke CC. The stability of gingerol and shogaol in aqueous solutions. J Pharm Sci. 2001;90(10):1658-1664.
16.   Phillips S, Hutchinson S and Ruggier R. Zingiber officinale does not affect gastric emptying rate. A randomised, placebo-controlled, crossover trial. Anaesthesia. 1993; 48(5):393-395.
17.   Huang Q, Iwamoto M and Aoki S. Anti-5-hydroxytryptamine3, effect of galanolactone, diterpenoid isolated from ginger. Chem Pharm Bull. 1991;39(2):397-399.
18.   Yamahara J, Rong HQ and Iwamoto M. Active components of ginger exhibiting anti-serotonergic action. PhytotherapyRes.1989;3(2):70-71.
19.   Yamahara J, Miki K, Chisaka T, Sawada T, Fujimura H, Tomimatsu T, Nakano K, and Nohara T. Cholagogic effect of ginger and its active constituents. J Ethnopharmacol. 1985;13(2):217-225.
20.   Thomson M, Al Qattan, KK Al Sawan SM, Alnaqeeb MA, Khan I and Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins LeukotEssent Fatty Acids. 2002;67(6):475-478.
21.   Westerterp-Plantenga M, Diepvens K, Joosen AM, Berube-Parent S and Tremblay A. Metabolic effects of spices, teas, and caffeine. Physiol Behav. 8-30-2006;89(1):85-91.
22.   Funk JL, Frye JB, Oyarzo JN, Timmermann BN. Comparative Effects of Two Gingerol-Containing Zingiber officinale Extracts on Experimental Rheumatoid ArthritisJ Nat Prod. 2009; 72:403-407.
23.   Kim J-K, Kim Y, Na, K-M, Surh Y-J and Kim T-Y. [6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo Free Rad Res. 2007;41:603-614.
24.   Beg T, Siddiqe Y S, Ara G, Gupta J and Afzal M; Antigenotoxic Effect of Genistein and gingerol on genotoxicity induced by norethandrolone and oxandrolone in cultured human lymphocytes. Int JPharmacol. 2008;4:177-183.
25.   Mustafa T, Srivastava KC. Ginger (Zingiber officinale) in migraine headache. Journal of Ethnopharmacology. 1990; 29:267-273.
26.   The Ayurvedic Pharmacopoeia of India, I Part, II Vol, Government of India, Ministry of Health and Family Welfare, Department of Ayush, India, 1999, 12-14. 17. 27) Dymock W, Warden CJH, Hooker D, Pharmacographia Indica, 3 Vol, Trubner and Co. Ltd, 1893, 435-437.
27.   Khare CP, Indian Medicinal Plants - An Illustrated Dictionary, Springer Science+BusinessMedia, LLC, 2007, 733-734. 19.
28.   The Siddha Pharmacopoeia of India, I Part, I Vol, Published by Central Council for Research in Ayurveda and Siddha, New Delhi, India, 2008, 69-71.